Healthcare
Tenet backs out of Healthscope, citing disclosure
US hospitals group Tenet Healthcare Corp. has announced its withdrawal from bidding for Australian hospitals and pathology business Healthscope Ltd., leaving the two rival private equity consortia - Kohlberg Kravis Roberts & Co. and CVC Capital Partners...
Tenet could be out for Healthscope
US hospitals group Tenet Healthcare Corp. may withdraw from bidding for Australian hospitals and pathology business Healthscope Ltd., leaving competition for the A$1.84 billion ($1.56 billion) deal to the two rival private equity consortia of Kohlberg...
Riverside invests Oz medical evaluator MLCOA
Global SME-focused private equity firm The Riverside Company has invested an undisclosed sum in Australian medical consultancy MLCOA, marking Riverside’s second acquisition in the market.
CVC said joining KKR Healthscope bid
CVC Capital Partners may be joining Kohlberg Kravis Roberts & Co. in its A$1.84 billion ($1.56 billion) bid for Australia's Healthscope Ltd., in contention against a consortium of the Carlyle Group and TPG Capital, as well as Dallas-headquartered US strategic...
Khazanah, Fortis – and GIC? – square off for Parkway
Malaysian SWF Khazanah Nasional and India’s Fortis Healthcare, with the rumored backing of SWF Government of Singapore Investment Corporation (GIC), appear locked in a fast-developing takeover tussle over Parkway Holdings, the Singapore hospitals business...
KKR, others cited for Healthscope
Kohlberg Kravis Roberts & Co. and an unnamed strategic bidder have been cited as the latest contenders for Australia's Healthscope Ltd., entering bids of around A$1.84 billion ($1.56 billion), marginally above the A$1.8 billion ($1.5 billion) already...
NEA, GTI invest India's Nova Medical
New Enterprise Associates and NYC-headquartered private equity firm GTI Group have invested $16 million in Series A funding for Nova Medical Centres, an Indian specialist surgical services provider based in Bangalore.
Khazanah seeks Parkway takeover
Malaysian SWF Khazanah Nasional is seeking to raise its stake in Parkway Holdings, the Singapore hospitals business recently exited by TPG Capital to India's Fortis Healthcare, from its present 23.5% to 51.5%, for some S$1.18 billion ($835 million).
KKR may invest India's Emcure
Kohlberg Kravis Roberts & Co. may be on the point of committing around $50 million into India's Emcure Pharmaceuticals, which until recently was also in discussions with the Blackstone Group, according to Indian sources.
Sequoia makes partial PathLabs exit
Sequoia Capital India is making a partial exit from its investment in Dr Lal PathLabs, a leading local diagnostics and pathology chain, selling around half of its 30% stake in the business, with a probable deal value of some $25.4 million.
Kleiner, Qiming invest China's Arrail Dental
Kleiner Perkins Caulfield & Byers China and Qiming Ventures have invested $20 million in Arrail Dental, a leading high-end PRC dental services provider, for an undisclosed stake.
Qiming invests China insulin with Gan & Lee
Qiming Venture Partners has committed just over $14.5 million to Gan & Lee Pharmaceutical Co. Ltd., a PRC manufacturer of insulin that claims to have Asia's largest recombinant insulin manufacturing site.
Warburg Pincus may join ICICI Metropolis bidding
Warburg Pincus has become the latest private equity firm to join the bidding for the 20% stake in Metropolis Healthcare held by ICICI Venture, which has also attracted interest from Apax Partners and TA Associates.
Healthscope: A healthy deal
The still-developing and much-covered privatization bid for Australian listed private healthcare provider Healthscope Ltd. by a consortium that now allegedly includes TPG, Carlyle and newcomer Blackstone is fast turning into a diagnostic test for the...
Queensland biotech fund gets Eli Lilly backing
The government of the Australian state of Queensland has partnered with pharmaceutical giant Eli Lilly & Co. to launch a $250 million biotech and life sciences VC fund.
Sequoia plans $54 million Star Health commitment
Sequoia Capital is close to agreeing a $54 million commitment to Star Health and Allied Insurance Co. Ltd., a Chennai-headquartered insurance company also invested by ICICI Venture recently for around $25.7 million.
IFC plans socially-focused India deals
The International Finance Corporation (IFC), the private sector arm of the World Bank, is working on two Indian socially-focused deals: a $25 million commitment to hospital chain Max Healthcare Institute, and participation in a $2.6 million fundraising...
Healthscope bidders raise price, nix breakup
The private equity bidders for ASX-listed hospital business Healthscope - still unconfirmed but widely reported as the Carlyle Group and TPG Capital - have raised their bid for the target to A$5.75 ($4.86) per share, totaling A$1.8 billion ($1.5 billion),...
Softbank China Venture helps Henghui dental play
Softbank China Venture Capital (SBCVC) has signed a strategic cooperation agreement with Henghui Technologies Co., Ltd., a company engaged in R&D and industrialization of digital oral cavity technology in China.
Oz healthcare play, by who?
Australian private hospital and pathology operator Healthscope acknowledged receipt of an A$1.74 billion ($1.55 billion) takeover offer from an unnamed private equity consortium.
GIC SI invests Fortis
GIC Special Investments, the private equity and alternatives arm of the Singapore SWF, is making an $84.5 million investment in India's Fortis Healthcare, for around 6.58% of the company's expanded capital.
Hepalink Shenzhen debut confirms Goldman result
The debut of Shenzhen Hepalink Pharmaceutical Co, Ltd. on the Shenzhen Stock Exchange on May 6th confirmed the expected result for investor Goldman Sachs, which reaped a 235x result on its $4.9 million 2007 investment.
Chinese heparin maker in historic IPO for Goldman
Shenzhen Hepalink Pharmaceutical Co, Ltd, is debuting on the Shenzhen Stock Exchange, selling up to 40.1 million shares at RMB148 ($21.68) each, the most expensive IPO price for a Chinese stock to date.
Shenzhen turns pig parts into gold?
Goldman Sachs seniors still trembling from their grilling before the US Senate and the news of a criminal probe by federal prosecutors could take comfort in at least one win for the reeling banking giant last week – the stellar IPO of Shenzhen Hepalink...